Pure Global AI
NCT06348121Not yet recruiting

Impact of Probiotics on Children With ADHD

Effect of WecProB on Clinical Features and Gut Microbiota of Attention Deficit Hyperactivity Disorder in Children
Wecare Probiotics Co., Ltd.ClinicalTrials.govdietary supplement
Verified
Study focus
Disease/Condition
Attention Deficit Hyperactivity Disorder
Drug/Device/Intervention
Probiotic
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Wecare Probiotics Co., Ltd.
Timeline & enrollment
Phase
N/A
Start date
May 07, 2024
End date
Dec 31, 2024
Enrollment
80 participants
Primary outcome

Clinical symptoms of ADHD

Summary

To evaluate the efficacy and safety of probiotic product WecProB as food supplements for the
 treatment of clinical symptoms in children with ADHD, in comparison with placebo.

ICD-10 classifications
Neurotic disorder, unspecifiedHyperkinetic disorder, unspecifiedHabit and impulse disorder, unspecifiedMild cognitive disorderDisturbance of activity and attention
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06348121
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06348121 through Pure Global AI's free database. This phase not specified trial is sponsored by Wecare Probiotics Co., Ltd. and is currently Not yet recruiting. The study focuses on Attention Deficit Hyperactivity Disorder. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.